Physician Assistant · Boise, ID
NPI
1629515440
Since 2017
Specialty
Physician Assistant
Code 363A00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
8854 W Emerald St Ste 180
Boise, ID, 83704
Phone (208) 229-9009
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
4,472 services
Medicare patients, 2024
497
Average age 74
Drug cost, 2024
$318K
3,758 prescriptions
Company payments, 2025
$127
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley Jenkins was code J0585 (injection, onabotulinumtoxina, 1 unit), 1,800 times for 14 patients. In total Ashley Jenkins billed 4,472 services in 53 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 1,800 | 14 | $4.99 | $8,983 |
| 81003 Clinical Chemistry | Office | 406 | 322 | $2.19 | $890 |
| 99213 Office E&M - Established | Office | 268 | 228 | $49.22 | $13K |
| 81001 Clinical Chemistry | Office | 199 | 151 | $3.10 | $617 |
| 99214 Office E&M - Established | Office | 169 | 144 | $72.95 | $12K |
| 51798 Ultrasound - Nonspecific | Office | 109 | 86 | $7.21 | $785 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 73 | 11 | $142.59 | $10K |
| 51702 Other Organ Systems | Office | 58 | 20 | $35.36 | $2,051 |
| 99232 Hospital E&M - Subsequent | Facility | 37 | 26 | $49.87 | $1,845 |
| 99441 Telephone Services | Office | 28 | 24 | $18.26 | $511 |
| 52000 Cystourethroscopy | Office | 20 | 19 | $142.16 | $2,843 |
| 52287 Cystourethroscopy | Office | 19 | 16 | $217.85 | $4,139 |
| 99203 Office E&M - New | Office | 15 | 15 | $43.52 | $653 |
| 74018 Standard X-ray | Office | 14 | 14 | $12.48 | $175 |
| 96402 Chemotherapy Administration | Office | 14 | 12 | $20.82 | $291 |
By year: 2022 $53K for 2,644 services; 2023 $57K for 5,433 services; 2024 $80K for 4,472 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 406 | 322 | $2.19 | $890 |
| 81001 Clinical Chemistry | 199 | 151 | $3.10 | $617 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashley Jenkins prescribed most often to Medicare patients was Tamsulosin Hcl, with 809 prescriptions and refills. In total Ashley Jenkins wrote 3,758 Medicare prescriptions that cost $318K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 809 | 1,671 | 233 | $6,773 |
| Finasteride Generic | 405 | 926 | 115 | $3,867 |
| Methenamine Hippurate Generic | 272 | 394 | 66 | $14K |
| Myrbetriq Mirabegron | 248 | 346 | 51 | $156K |
| Trospium Chloride Generic | 228 | 302 | 52 | $7,456 |
| Cephalexin Generic | 189 | 284 | 69 | $2,199 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 182 | 302 | 45 | $1,735 |
| Solifenacin Succinate Generic | 164 | 310 | 38 | $5,690 |
| Levofloxacin Generic | 148 | 148 | 121 | $321 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 102 | 204 | 25 | $871 |
| Tolterodine Tartrate Generic | 96 | 123 | 22 | $3,356 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 62 | 62 | 48 | $723 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 58 | 76 | 11 | $1,218 |
| Doxazosin Mesylate Generic | 52 | 120 | 12 | $808 |
| Ciprofloxacin Hcl Generic | 50 | 67 | 33 | $366 |
Brand drugs: - claims; generic drugs: 3,409 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley Jenkins $127 ($127 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $127.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 3 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.